US Stem Cell Inc (USRM)
OTHER OTC:USRM
Holding USRM?
Track your performance easily

US Stem Cell (USRM) Income Statement

26 Followers

US Stem Cell Income Statement

Last quarter (Q ), US Stem Cell's total revenue was $8.05K, a decrease of -65.88% from the same quarter last year. In Q, US Stem Cell's net income was $-566.62K. See US Stem Cell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 66.54K$ 82.05K$ 200.75K$ 277.09K$ 3.07M$ 6.70M
Cost of Revenue
$ -23.77K$ -23.77K$ -52.03K$ 64.12K$ 1.34M$ 2.11M
Gross Profit
$ 58.28K$ 58.28K$ 252.78K$ 212.97K$ 1.74M$ 4.59M
Operating Expense
$ -1.78M$ -1.78M$ -2.28M$ 2.61M$ 5.15M$ 5.69M
Operating Income
$ 1.88M$ 1.88M$ 2.54M$ -2.40M$ -3.42M$ -1.10M
Net Non Operating Interest Income Expense
$ -689.98K$ -689.98K$ -1.00M$ -488.37K$ -981.00K$ -1.44M
Other Income Expense
$ -442.37K$ 447.48K$ 151.41K$ -1.88K$ 562.52K$ 382.28K
Pretax Income
$ -2.86M$ -2.86M$ 1.39M$ -2.89M$ -3.84M$ -2.16M
Tax Provision
$ -1.52M$ -1.52M$ -1.02M$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -2.86M$ -2.86M$ 1.39M$ -2.89M$ -3.84M$ -2.16M
Basic EPS
$ >-0.01--$ -0.01$ -0.01$ -0.01
Diluted EPS
$ >-0.01--$ -0.01$ -0.01$ -0.01
Basic Average Shares
$ 1.12B--$ 429.29M$ 398.04M$ 365.64M
Diluted Average Shares
$ 1.12B--$ 429.29M$ 398.04M$ 365.64M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -2.62M$ -1.80M$ -2.34M$ 2.68M$ 6.49M$ 7.80M
Net Income From Continuing And Discontinued Operation
$ -2.86M$ -566.62K$ 1.39M$ -2.89M$ -3.84M$ -2.16M
Normalized Income
$ -1.28M--$ -2.91M$ -3.96M$ -2.29M
Interest Expense
$ 329.49K--$ 488.37K$ 981.00K$ 1.44M
EBIT
$ -2.17M$ -2.17M$ 2.39M$ -2.40M$ -2.85M$ -715.62K
EBITDA
$ -1.81M$ -2.17M$ 3.36M$ -2.40M$ -2.61M$ -508.49K
Currency in USD

US Stem Cell Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis